Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10420978 | 1.00 | USP2 (0.53) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL10420136 | 0.98 | USP2 (0.50) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL2139322 | 0.82 | USP2 (0.53) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL10559210 | 0.82 | USP2 (0.53) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL5350631 | 0.81 | USP2 (0.51) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL2590611 | 0.81 | USP2 (0.51) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL7867560 | 0.81 | USP2 (0.51) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL28391309 | 0.79 | USP2 (0.50) | USP2LMNAKDM4EDUSP3MEN1 | |
| SCHEMBL9478457 | 0.79 | USP2 (0.33) | USP2HTT | |
| SCHEMBL1841790 | 0.79 | USP2 (0.49) | USP2LMNAKDM4EDUSP3MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1160232-B1 | Process for production of monoalkyl ethers | KAO CORP (JP) | 2003-08-20 | — | — | EP | disclosed |
| US-6504063-B2 | Hydrogenation polyol in aqueous solution | KAO CORPORATION (JP) | 2003-01-07 | — | — | US | disclosed |
| US-20010056212-A1 | Process for production of monoalkyl ethers | KAO CORPORATION (JP) | 2001-12-27 | — | — | US | disclosed |
| EP-1160232-A2 | Process for production of monoalkyl ethers | Kao Corporation (JP) | 2001-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056212-A1 | Process for production of monoalkyl ethers | PHOSPHO1, HDHD5, PLTP | USP2 1288/4885LMNA 4476/4885KDM4E 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.